Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dendritic Cells | 6 | 2023 | 2749 | 0.770 |
Why?
|
Histiocytes | 2 | 2022 | 97 | 0.770 |
Why?
|
Leukemia, Myeloid, Acute | 4 | 2024 | 3620 | 0.650 |
Why?
|
Dendritic Cell Sarcoma, Follicular | 2 | 2017 | 30 | 0.650 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 4 | 2022 | 1428 | 0.610 |
Why?
|
Ultraviolet Rays | 1 | 2023 | 1100 | 0.600 |
Why?
|
Tumor Escape | 1 | 2021 | 372 | 0.590 |
Why?
|
Antigens | 1 | 2022 | 1443 | 0.540 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2021 | 697 | 0.540 |
Why?
|
Interferons | 3 | 2023 | 717 | 0.520 |
Why?
|
NF-kappa B p52 Subunit | 1 | 2015 | 35 | 0.520 |
Why?
|
Lymphoma, T-Cell | 1 | 2017 | 303 | 0.490 |
Why?
|
Autoimmune Diseases | 2 | 2020 | 2257 | 0.480 |
Why?
|
Immunity, Cellular | 1 | 2020 | 1561 | 0.470 |
Why?
|
Gene Silencing | 1 | 2021 | 1501 | 0.470 |
Why?
|
Immunity, Innate | 3 | 2024 | 3079 | 0.470 |
Why?
|
Histones | 2 | 2024 | 2593 | 0.460 |
Why?
|
Immunologic Memory | 1 | 2020 | 1374 | 0.450 |
Why?
|
Inflammation | 9 | 2024 | 10863 | 0.440 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2023 | 2846 | 0.430 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2015 | 710 | 0.400 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2013 | 515 | 0.380 |
Why?
|
Toll-Like Receptor 2 | 1 | 2013 | 348 | 0.370 |
Why?
|
Myeloproliferative Disorders | 3 | 2022 | 614 | 0.360 |
Why?
|
Neutrophil Infiltration | 1 | 2012 | 395 | 0.330 |
Why?
|
Skin | 1 | 2023 | 4499 | 0.330 |
Why?
|
T-Lymphocytes | 5 | 2022 | 10266 | 0.310 |
Why?
|
Skin Neoplasms | 3 | 2023 | 5857 | 0.310 |
Why?
|
Hematologic Neoplasms | 4 | 2023 | 1906 | 0.310 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2013 | 977 | 0.290 |
Why?
|
NF-kappa B | 1 | 2015 | 2487 | 0.280 |
Why?
|
Dioxygenases | 3 | 2024 | 351 | 0.260 |
Why?
|
Interleukin-17 | 1 | 2012 | 922 | 0.260 |
Why?
|
Mediastinal Neoplasms | 2 | 2019 | 403 | 0.260 |
Why?
|
Cytokines | 1 | 2020 | 7443 | 0.250 |
Why?
|
Melanoma, Experimental | 2 | 2019 | 559 | 0.250 |
Why?
|
Antiviral Agents | 1 | 2018 | 3064 | 0.250 |
Why?
|
Myocarditis | 1 | 2013 | 803 | 0.250 |
Why?
|
Ovarian Neoplasms | 1 | 2022 | 4908 | 0.240 |
Why?
|
Interferon-gamma | 1 | 2013 | 3164 | 0.240 |
Why?
|
Nitric Oxide | 1 | 2013 | 2143 | 0.230 |
Why?
|
Immune Tolerance | 1 | 2013 | 2324 | 0.220 |
Why?
|
Mutation | 12 | 2024 | 30230 | 0.220 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2023 | 97 | 0.220 |
Why?
|
Thiadiazoles | 1 | 2023 | 63 | 0.220 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2023 | 50 | 0.220 |
Why?
|
Myeloid Progenitor Cells | 1 | 2023 | 112 | 0.220 |
Why?
|
Naphthalenes | 1 | 2023 | 198 | 0.210 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2014 | 4357 | 0.190 |
Why?
|
Histone Demethylases | 1 | 2024 | 322 | 0.190 |
Why?
|
Janus Kinase 2 | 1 | 2024 | 561 | 0.190 |
Why?
|
Endothelial Cells | 3 | 2014 | 3587 | 0.190 |
Why?
|
Hepatitis | 1 | 2023 | 227 | 0.180 |
Why?
|
Cell Movement | 2 | 2014 | 5214 | 0.180 |
Why?
|
Nissl Bodies | 1 | 2020 | 16 | 0.180 |
Why?
|
Interleukin-1beta | 2 | 2024 | 1020 | 0.180 |
Why?
|
Signal Transduction | 6 | 2024 | 23629 | 0.170 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2016 | 1408 | 0.170 |
Why?
|
Atherosclerosis | 2 | 2014 | 3431 | 0.170 |
Why?
|
Clone Cells | 1 | 2023 | 1671 | 0.170 |
Why?
|
Macrophages | 3 | 2019 | 5796 | 0.160 |
Why?
|
Menopause, Premature | 1 | 2020 | 124 | 0.160 |
Why?
|
Animals | 21 | 2024 | 169322 | 0.160 |
Why?
|
Ribonucleoproteins | 1 | 2021 | 359 | 0.160 |
Why?
|
Myeloid Cells | 1 | 2023 | 832 | 0.160 |
Why?
|
Humans | 48 | 2024 | 768298 | 0.160 |
Why?
|
Penicillin G Benzathine | 1 | 2018 | 25 | 0.160 |
Why?
|
Histiocytic Sarcoma | 1 | 2019 | 40 | 0.160 |
Why?
|
Leukemia, Biphenotypic, Acute | 1 | 2018 | 32 | 0.160 |
Why?
|
Stem Cell Transplantation | 2 | 2017 | 1601 | 0.150 |
Why?
|
Antibodies, Blocking | 1 | 2019 | 250 | 0.150 |
Why?
|
Organ Specificity | 1 | 2023 | 1966 | 0.150 |
Why?
|
Receptors, Interleukin-6 | 1 | 2019 | 224 | 0.150 |
Why?
|
Bone Marrow Cells | 2 | 2023 | 2414 | 0.150 |
Why?
|
Mice | 16 | 2023 | 82004 | 0.150 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2020 | 210 | 0.150 |
Why?
|
Cell Death | 1 | 2023 | 1681 | 0.150 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2019 | 125 | 0.140 |
Why?
|
Enteric Nervous System | 1 | 2020 | 213 | 0.140 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2021 | 1362 | 0.140 |
Why?
|
DNA Transposable Elements | 1 | 2021 | 762 | 0.140 |
Why?
|
Antigens, Viral | 1 | 2021 | 992 | 0.140 |
Why?
|
Loss of Heterozygosity | 2 | 2017 | 663 | 0.140 |
Why?
|
Single-Cell Analysis | 4 | 2022 | 2533 | 0.140 |
Why?
|
Flow Cytometry | 3 | 2019 | 5898 | 0.140 |
Why?
|
Adenosine Deaminase | 1 | 2018 | 252 | 0.130 |
Why?
|
DNA, Mitochondrial | 1 | 2022 | 871 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2016 | 190 | 0.130 |
Why?
|
Disease Susceptibility | 1 | 2023 | 1795 | 0.130 |
Why?
|
Bacillus cereus | 1 | 2015 | 36 | 0.130 |
Why?
|
Neoplasms | 2 | 2023 | 22389 | 0.130 |
Why?
|
Syphilis | 1 | 2018 | 243 | 0.130 |
Why?
|
Tumor Microenvironment | 4 | 2023 | 3940 | 0.120 |
Why?
|
Hematopoietic Stem Cells | 3 | 2023 | 3407 | 0.120 |
Why?
|
Gout | 1 | 2022 | 621 | 0.120 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2019 | 808 | 0.120 |
Why?
|
Chromosomes, Human | 1 | 2017 | 444 | 0.120 |
Why?
|
Meningoencephalitis | 1 | 2015 | 83 | 0.120 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 384 | 0.120 |
Why?
|
NF-kappa B p50 Subunit | 1 | 2014 | 103 | 0.120 |
Why?
|
Cardiovascular Diseases | 4 | 2023 | 15652 | 0.110 |
Why?
|
Cell Lineage | 1 | 2023 | 2574 | 0.110 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2021 | 1795 | 0.110 |
Why?
|
Bone Marrow Neoplasms | 1 | 2014 | 101 | 0.110 |
Why?
|
ras Proteins | 1 | 2019 | 1058 | 0.110 |
Why?
|
Transcription Factor RelA | 1 | 2014 | 254 | 0.110 |
Why?
|
Autoantibodies | 1 | 2022 | 2126 | 0.110 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 1105 | 0.100 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2015 | 342 | 0.100 |
Why?
|
Hematopoiesis | 4 | 2023 | 2058 | 0.100 |
Why?
|
Genes, Tumor Suppressor | 1 | 2017 | 1064 | 0.100 |
Why?
|
Endothelium, Vascular | 3 | 2014 | 4427 | 0.100 |
Why?
|
Liver Cirrhosis | 1 | 2023 | 1957 | 0.100 |
Why?
|
Cell-Derived Microparticles | 1 | 2014 | 161 | 0.100 |
Why?
|
Gene Expression Profiling | 2 | 2019 | 9508 | 0.100 |
Why?
|
Leukocyte Rolling | 1 | 2012 | 69 | 0.100 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2022 | 3666 | 0.100 |
Why?
|
Osteoporosis | 1 | 2021 | 1606 | 0.100 |
Why?
|
Hodgkin Disease | 1 | 2019 | 1386 | 0.100 |
Why?
|
Genetic Engineering | 1 | 2017 | 936 | 0.100 |
Why?
|
Virus Diseases | 1 | 2018 | 723 | 0.100 |
Why?
|
Coronary Artery Disease | 2 | 2022 | 6566 | 0.100 |
Why?
|
MAP Kinase Signaling System | 1 | 2019 | 1492 | 0.100 |
Why?
|
Postmenopause | 1 | 2020 | 2518 | 0.090 |
Why?
|
Venous Thromboembolism | 1 | 2024 | 1881 | 0.090 |
Why?
|
Chromatin | 2 | 2021 | 2967 | 0.090 |
Why?
|
Female | 25 | 2024 | 397050 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2016 | 997 | 0.090 |
Why?
|
Lymphoma, B-Cell | 1 | 2017 | 945 | 0.090 |
Why?
|
Transcription Factors | 2 | 2024 | 12166 | 0.090 |
Why?
|
Immunocompromised Host | 1 | 2015 | 863 | 0.090 |
Why?
|
Virus Replication | 1 | 2018 | 2458 | 0.090 |
Why?
|
Immunotherapy | 2 | 2023 | 4740 | 0.080 |
Why?
|
RNA-Binding Proteins | 1 | 2018 | 1883 | 0.080 |
Why?
|
Interleukin-6 | 1 | 2019 | 3230 | 0.080 |
Why?
|
RNA, Viral | 1 | 2018 | 2866 | 0.080 |
Why?
|
Immunophenotyping | 3 | 2019 | 1866 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4647 | 0.080 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2020 | 3612 | 0.080 |
Why?
|
Mice, Mutant Strains | 1 | 2012 | 1755 | 0.080 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2017 | 3794 | 0.080 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2011 | 660 | 0.080 |
Why?
|
Mice, Inbred C57BL | 6 | 2020 | 22355 | 0.080 |
Why?
|
Health Status | 1 | 2021 | 4094 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2023 | 5335 | 0.070 |
Why?
|
Chemokines | 1 | 2012 | 962 | 0.070 |
Why?
|
Inflammasomes | 2 | 2023 | 540 | 0.070 |
Why?
|
Genomics | 3 | 2019 | 5916 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2019 | 3609 | 0.070 |
Why?
|
Sulfonamides | 1 | 2016 | 1980 | 0.070 |
Why?
|
Male | 22 | 2024 | 364870 | 0.070 |
Why?
|
Aged | 14 | 2024 | 171544 | 0.070 |
Why?
|
Adult | 16 | 2024 | 223622 | 0.070 |
Why?
|
Middle Aged | 16 | 2024 | 223463 | 0.070 |
Why?
|
Cross Infection | 1 | 2015 | 1422 | 0.070 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2019 | 8628 | 0.070 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2017 | 1643 | 0.070 |
Why?
|
RNA, Messenger | 1 | 2020 | 12801 | 0.060 |
Why?
|
Disease Models, Animal | 2 | 2023 | 18358 | 0.060 |
Why?
|
Stem Cells | 1 | 2018 | 3537 | 0.060 |
Why?
|
Mice, Knockout | 3 | 2021 | 14481 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4584 | 0.060 |
Why?
|
Diet | 1 | 2021 | 8097 | 0.050 |
Why?
|
Sequence Analysis, RNA | 2 | 2022 | 2038 | 0.050 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2018 | 3111 | 0.050 |
Why?
|
Colonic Neoplasms | 1 | 2014 | 2542 | 0.050 |
Why?
|
Cell Line, Tumor | 4 | 2019 | 17132 | 0.050 |
Why?
|
Anti-Inflammatory Agents | 1 | 2011 | 1812 | 0.050 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2022 | 173 | 0.050 |
Why?
|
DNA-Binding Proteins | 3 | 2024 | 9618 | 0.050 |
Why?
|
Neurons | 1 | 2020 | 9512 | 0.050 |
Why?
|
Endoplasmic Reticulum, Rough | 1 | 2020 | 21 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 3 | 2020 | 18047 | 0.040 |
Why?
|
Blood Cell Count | 1 | 2021 | 402 | 0.040 |
Why?
|
Alendronate | 1 | 2021 | 174 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5802 | 0.040 |
Why?
|
Reed-Sternberg Cells | 1 | 2019 | 78 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2018 | 7458 | 0.040 |
Why?
|
Mice, Congenic | 1 | 2019 | 98 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2023 | 1704 | 0.040 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2020 | 691 | 0.040 |
Why?
|
Olfactory Bulb | 1 | 2019 | 198 | 0.040 |
Why?
|
Lymphocytic Choriomeningitis | 1 | 2019 | 140 | 0.040 |
Why?
|
Circadian Clocks | 1 | 2020 | 168 | 0.040 |
Why?
|
Lysosomes | 1 | 2023 | 939 | 0.040 |
Why?
|
Ileum | 1 | 2020 | 558 | 0.040 |
Why?
|
Lymphocytic choriomeningitis virus | 1 | 2019 | 175 | 0.040 |
Why?
|
Lymphocyte Subsets | 1 | 2019 | 313 | 0.040 |
Why?
|
Osteoclasts | 1 | 2021 | 711 | 0.040 |
Why?
|
Tissue Array Analysis | 1 | 2019 | 551 | 0.040 |
Why?
|
Interferon-alpha | 1 | 2022 | 910 | 0.040 |
Why?
|
RNA Editing | 1 | 2018 | 149 | 0.040 |
Why?
|
RNA, Double-Stranded | 1 | 2018 | 293 | 0.040 |
Why?
|
Ribosomes | 1 | 2020 | 499 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2019 | 354 | 0.030 |
Why?
|
Risk Factors | 5 | 2024 | 74954 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2017 | 6856 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2014 | 6404 | 0.030 |
Why?
|
Interleukins | 1 | 2021 | 795 | 0.030 |
Why?
|
Cell Adhesion | 2 | 2014 | 3101 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2018 | 9197 | 0.030 |
Why?
|
Uric Acid | 1 | 2022 | 806 | 0.030 |
Why?
|
Doxycycline | 1 | 2018 | 347 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 3252 | 0.030 |
Why?
|
Contact Tracing | 1 | 2018 | 275 | 0.030 |
Why?
|
Apoptosis | 2 | 2022 | 9506 | 0.030 |
Why?
|
Intestinal Diseases | 1 | 2020 | 505 | 0.030 |
Why?
|
Gender Identity | 1 | 2021 | 770 | 0.030 |
Why?
|
Drug Therapy | 1 | 2018 | 504 | 0.030 |
Why?
|
Ligands | 1 | 2022 | 3283 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2021 | 1780 | 0.030 |
Why?
|
Anemia, Myelophthisic | 1 | 2014 | 6 | 0.030 |
Why?
|
Stromal Cells | 1 | 2020 | 1337 | 0.030 |
Why?
|
SOXF Transcription Factors | 1 | 2014 | 31 | 0.030 |
Why?
|
Neuroglia | 1 | 2020 | 960 | 0.030 |
Why?
|
Tumor Lysis Syndrome | 1 | 2014 | 38 | 0.030 |
Why?
|
Prevalence | 2 | 2021 | 15868 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2023 | 2207 | 0.030 |
Why?
|
Disease Progression | 2 | 2023 | 13646 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2021 | 59683 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2016 | 13696 | 0.030 |
Why?
|
Neck | 1 | 2018 | 736 | 0.030 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2014 | 187 | 0.030 |
Why?
|
Survival Rate | 2 | 2017 | 12870 | 0.030 |
Why?
|
Azepines | 1 | 2014 | 329 | 0.030 |
Why?
|
Homozygote | 1 | 2017 | 1779 | 0.030 |
Why?
|
Colon | 1 | 2020 | 1805 | 0.030 |
Why?
|
E-Selectin | 1 | 2014 | 578 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2024 | 4526 | 0.020 |
Why?
|
Incidence | 2 | 2021 | 21544 | 0.020 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2014 | 692 | 0.020 |
Why?
|
Acetylation | 1 | 2014 | 1053 | 0.020 |
Why?
|
Prospective Studies | 3 | 2021 | 54921 | 0.020 |
Why?
|
Reference Values | 1 | 2019 | 4941 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 2006 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2016 | 2127 | 0.020 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2018 | 1248 | 0.020 |
Why?
|
Women's Health | 1 | 2020 | 2078 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2019 | 2046 | 0.020 |
Why?
|
Odds Ratio | 1 | 2023 | 9681 | 0.020 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2014 | 792 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2021 | 2986 | 0.020 |
Why?
|
RNA Polymerase II | 1 | 2014 | 547 | 0.020 |
Why?
|
Trans-Activators | 1 | 2019 | 2855 | 0.020 |
Why?
|
Gene Knock-In Techniques | 1 | 2011 | 423 | 0.020 |
Why?
|
Phenotype | 2 | 2018 | 16716 | 0.020 |
Why?
|
Nervous System Diseases | 1 | 2020 | 1664 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2016 | 10464 | 0.020 |
Why?
|
Gene Deletion | 1 | 2017 | 2673 | 0.020 |
Why?
|
Risk | 1 | 2021 | 9635 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2014 | 1837 | 0.020 |
Why?
|
Triazoles | 1 | 2014 | 904 | 0.020 |
Why?
|
RNA | 1 | 2019 | 2726 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2018 | 2568 | 0.020 |
Why?
|
Bone Marrow | 1 | 2019 | 2929 | 0.020 |
Why?
|
Prognosis | 2 | 2019 | 30020 | 0.020 |
Why?
|
Mitochondria | 1 | 2022 | 3675 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2020 | 3692 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2016 | 3616 | 0.020 |
Why?
|
DNA Methylation | 1 | 2022 | 4419 | 0.020 |
Why?
|
Base Sequence | 1 | 2019 | 12421 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2020 | 9563 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2014 | 1368 | 0.020 |
Why?
|
Young Adult | 3 | 2019 | 60048 | 0.020 |
Why?
|
Cell Survival | 1 | 2016 | 5792 | 0.020 |
Why?
|
Adaptive Immunity | 1 | 2011 | 731 | 0.020 |
Why?
|
Cell Separation | 1 | 2011 | 1725 | 0.020 |
Why?
|
Adolescent | 3 | 2019 | 89182 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12557 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2016 | 11854 | 0.010 |
Why?
|
Genotype | 1 | 2019 | 13038 | 0.010 |
Why?
|
Forkhead Transcription Factors | 1 | 2011 | 1622 | 0.010 |
Why?
|
Survival Analysis | 1 | 2016 | 10117 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2021 | 11659 | 0.010 |
Why?
|
Antigens, CD | 1 | 2014 | 4031 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 13019 | 0.010 |
Why?
|
Protein Binding | 1 | 2014 | 9346 | 0.010 |
Why?
|
Aging | 1 | 2020 | 8764 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 13082 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2014 | 7599 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5711 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 16027 | 0.010 |
Why?
|
Child | 2 | 2019 | 80894 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39405 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2014 | 19019 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2017 | 81768 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2014 | 6670 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2014 | 14783 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 41791 | 0.010 |
Why?
|
Infant | 1 | 2018 | 36512 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2011 | 8051 | 0.010 |
Why?
|
Child, Preschool | 1 | 2018 | 42654 | 0.010 |
Why?
|
United States | 1 | 2021 | 73144 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2019 | 21163 | 0.010 |
Why?
|
HIV Infections | 1 | 2018 | 17575 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20766 | 0.010 |
Why?
|
Brain | 1 | 2018 | 27452 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2016 | 65365 | 0.010 |
Why?
|